A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original...

Health Organization's List of Essential Medicines. It is available as a biosimilar medication. In 2022, it was the 241st most commonly prescribed medication...

novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold...

States in 1998, and in the European Union in August 1999. Infliximab biosimilars have been approved in the EU (2013), in Japan (2014), and in the United...

Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was...

"EMA Approves First MAb Biosimilars". BioPharma-reporter.com. "Biosimilar trastuzumab approved in Korea". Generics and Biosimilars Initiative. 17 January...

follow-on biosimilars will exhibit variability in specific variants over time. The safety and clinical performance of both originator and biosimilar biopharmaceuticals...

It is a biosimilar to Eylea. In August 2024, aflibercept-abzv (Enzeevu) was approved for medical use in the United States. It is a biosimilar to Eylea...

context of ankylosing spondylitis, biosimilars are typically used as alternatives to the original biologic drugs. Biosimilars for ankylosing spondylitis may...

clinical data demonstrating that Herzuma is biosimilar to US Herceptin. Herzuma has been approved as a biosimilar, not as an interchangeable product. Kanjinti...

Rituximab Patent". Center for Biosimilars. Retrieved 27 July 2024. "Biosimilars of Rituximab". Generics and Biosimilars Initiative. 14 April 2017. Archived...

Act of 2009) do have in place a system to approve generic biologics (biosimilars) which "requires mandatory clinical testing and periodic review". In...

clear solution as there is no zinc in formula.[better source needed] The biosimilar insulin glargine-yfgn (Semglee) was approved for medical use in the United...

the World Health Organization's List of Essential Medicines. Filgrastim biosimilar medications are available. Filgrastim is used to treat neutropenia; acute...

the US Food and Drug Administration (FDA) approved an interchangeable biosimilar insulin product called Semglee (insulin glargine-yfgn) for the treatment...

applicant for this medicinal product is STADA Arzneimittel AG. Uzpruvo is a biosimilar medicinal product. Uzpruvo was authorized for medical use in the European...

September 2021. In India, Lupin Limited received marketing approval for its biosimilar of Ranibizumab. In June 2022, the Committee for Medicinal Products for...

Pharma launches biosimilar in Europe". The Hindu. ISSN 0971-751X. Retrieved 3 October 2021. "Intas Pharmaceuticals launches biosimilar in Europe". The...

from Sandoz for Jubbonti (denosumab-bbdz), a biosimilar to Prolia; and Wyost (denosumab-bbdz), a biosimilar to Xgeva. In December 2009, the Committee for...

system for biosimilars". BioPharma-Reporter. Archived from the original on 10 January 2016. Retrieved 18 March 2020. "FDA approves first biosimilar for the...

the first tocilizumab biosimilar approved for medical use in the European Union, and in March 2024, became the first biosimilar with both intravenous...

Teva Generics has been authorized for marketing in the European Union. Biosimilar product from Gedeon Richter plc has been authorized in the European Union...

monoclonal antibodies, differ biologically from small-molecule drugs. Biosimilars have active pharmaceutical ingredients that are almost identical to the...

active pharmaceutical ingredients (APIs), formulations, biologics and biosimilars, and vaccines. Various types of companies are within these segments....

the biosimilar space has included a 2017 partnership with Adello Biologics (for the collaborative development of Neupogen and Neuasta biosimilars) and...

name pharmaceutical companies. Its sister company Alvotech produces biosimilars. Alvogen was founded in 2009 by Robert Wessman, who stepped down from...

developing biosimilars for global markets, including the US and EU. Arven has obtained a marketing authorization in 2016 for the biosimilar of Filgrastim...

Nations Industrial Development Organization Public health Generic drugs biosimilar Pharmaceutical patents criticism Test data exclusivity Doha Declaration...

ADCs. Samsung Bioepis’s biosimilar product Opuviz has been approved by the European Commission, according to the Korean biosimilar developer on Nov. 2024...

Ltda. In 2014, Cadila Healthcare launched the world's first adalimumab biosimilar under the brand name Exemptia at one-fifth the originator's price. Zydus...